Blood pressure dynamics during exercise rehabilitation in heart failure patients. (29th August 2020)

• Record Type: Journal Article
• Authors: Hecht, Idan; Arad, Michael; Freimark, Dov; Klempfner, Robert
• Is Part Of: European journal of preventive cardiology. Volume 24:Number 8(2017)
• Page Start: 818
• Page End: 824
• Publication Date: 2020-08-29
• Subjects: Heart failure -- cardiac rehabilitation -- blood pressure response to exercise; Cardiovascular system -- Diseases -- Prevention -- Periodicals; Cardiac patients -- Rehabilitation -- Periodicals; 616.12
• DOI: 10.1177/2047487317690951
• Languages: English
• ISSNs: 2047-4873

Abstract

Abstract: Background: Patients suffering from heart failure (HF) may demonstrate an abnormal blood pressure response to exercise (ABPRE), which may revert to a normal one following medical treatment. It is assumed that this change correlates positively with prognosis and functional aspects. The aim of this study was to characterize patients with ABPRE and assess ABPRE normalization and the correlation with clinical and functional outcomes. Methods: In the study, 651 patients with HF who underwent cardiac rehabilitation (CR) were examined. Patients who presented an ABPRE during stress testing were identified and divided into those who corrected their initial ABPRE following CR and those who did not. Results: Pre-rehabilitation ABPRE was present in 27% of patients, 68% of whom normalized their ABPRE following CR. Two parameters were independently predictive of failure to normalize the blood pressure response: female gender (odds ratio (OR) 3.5; 95% confidence interval (CI) 1.4–9.0) and decreased systolic function (OR 3.2; 95% CI 1.0–9.4). Patients with hypertrophic cardiomyopathy demonstrated higher rates of ABPRE normalization than patients with other causes of HF (93% vs. 62%, respectively, P = 0.03). The research population exhibited an average improvement in exercise capacity (4.7 to 6.4 metabolic equivalents (METS), P < .001), ejection fraction (35.4% to 37.7%, P < .001) and percentage of patients with New York Heart Association (NYHA) class 3–4 (50% to 43.4%, P = .123). The group who normalized their ABPRE exhibited greater improvement. Conclusions: Amongst a population of patients suffering from HF, an ABPRE was normalized following CR in two thirds of patients. Female gender and a reduced systolic function independently predicted the failure to correct the ABPRE, while patients with hypertrophic cardiomyopathy demonstrated exceptionally high rates of normalization.